{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:58:45Z","timestamp":1793249925935,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The thermal stability of viruses in gelatin liquid formulations for medical research and application is poorly understood and this study aimed to examine the thermal stability of 4 enveloped and nonenveloped DNA and RNA viruses in hydrolyzed gelatin liquid formulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Bovine herpesvirus (BHV) was used as a model virus to examine the molecular weight (MW), concentration and gelatin type and to optimize virus stability in liquid formulations at 25\u00a0\u00b0C and 4\u00a0\u00b0C. Using the model virus liquid formulation, the stability of multiple enveloped and nonenveloped RNA and DNA viruses, including parainfluenza virus, reovirus (RV), BHV, and adenovirus (AdV), was monitored over up to a 30-week storage period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The BHV model virus was considered stable after 3\u00a0weeks in hydrolyzed gelatin (MW: 4000) with a 0.8 LRV (log10 reduction value) at 25\u00a0\u00b0C or a 0.2 LRV at 4\u00a0\u00b0C, compared to the stabilities observed in higher MW gelatin (60,000 and 160,000) with an LRV above 1. Based on the gelatin type, BHV in alkaline-treated hydrolyzed gelatin samples were unexpectantly more stable than in acid-treated hydrolyzed gelatin sample. All four viruses exhibited stability at 4\u00a0\u00b0C for at least 8\u00a0weeks, BHV or AdV remained stable for over 30\u00a0weeks of storage, and at 25\u00a0\u00b0C, AdV and RV remained stable for 8\u00a0weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results demonstrated that 5% of 4000\u00a0MW hydrolyzed gelatin formulation can act as a relevant stabilizer for the thermal stability of viruses in medical research and application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-022-01819-w","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T11:02:59Z","timestamp":1653649379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Stability of enveloped and nonenveloped viruses in hydrolyzed gelatin liquid formulation"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9187-4584","authenticated-orcid":false,"given":"Francois Marie Ngako","family":"Kadji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuro","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"issue":"6","key":"1819_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1139\/m75-121","volume":"21","author":"MC Mahl","year":"1975","unstructured":"Mahl MC, Sadler C. Virus survival on inanimate surfaces. Can J Microbiol. 1975;21(6):819\u201323.","journal-title":"Can J Microbiol"},{"issue":"2","key":"1819_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1264\/jsme2.ME14145","volume":"30","author":"S Firquet","year":"2015","unstructured":"Firquet S, Beaujard S, Lobert PE, San\u00e9 F, Caloone D, Izard D, Hober D. Survival of enveloped and non-enveloped viruses on inanimate surfaces. Microbes Environ. 2015;30(2):140\u20134.","journal-title":"Microbes Environ"},{"key":"1819_CR3","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/B978-0-12-415894-8.00038-5","volume-title":"Animal models for the study of human disease","author":"SI Ruiz","year":"2013","unstructured":"Ruiz SI, Zumbrun EE, Nalca A. Animal models of human viral diseases. In: Conn PM, editor. Animal models for the study of human disease. New York: Elsevier; 2013. p. 927\u201370."},{"issue":"4","key":"1819_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2471\/BLT.16.175166","volume":"95","author":"A Hsiao","year":"2017","unstructured":"Hsiao A, Desai SN, Mogasale V, Excler JL, Digilio L. Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings. Bull World Health Organ. 2017;95(4):303\u201312.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"1819_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11095-021-03008-w","volume":"38","author":"YB Yu","year":"2021","unstructured":"Yu YB, Briggs KT, Taraban MB, Brinson RG, Marino JP. Grand challenges in pharmaceutical research series: ridding the cold chain for biologics. Pharm Res. 2021;38(1):3\u20137.","journal-title":"Pharm Res"},{"issue":"42","key":"1819_CR6","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1016\/j.vaccine.2015.08.085","volume":"33","author":"LJJ Hansen","year":"2015","unstructured":"Hansen LJJ, Daoussi R, Vervaet C, Remon JP, De Beer TRM. Freeze-drying of live virus vaccines: a review. Vaccine. 2015;33(42):5507\u201319.","journal-title":"Vaccine"},{"issue":"11","key":"1819_CR7","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1007\/s10529-015-1907-0","volume":"37","author":"K Su","year":"2015","unstructured":"Su K, Wang C. Recent advances in the use of gelatin in biomedical research. Biotechnol Lett. 2015;37(11):2139\u201345.","journal-title":"Biotechnol Lett"},{"issue":"5","key":"1819_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4161\/hv.4.5.5863","volume":"4","author":"J Kissmann","year":"2008","unstructured":"Kissmann J, Ausar SF, Rudolph A, Braun C, Cape SP, Sievers RE, Federspiel MJ, Joshi SB, Middaugh CR. Stabilization of measles virus for vaccine formulation. Hum Vaccin. 2008;4(5):350\u20139.","journal-title":"Hum Vaccin"},{"issue":"3","key":"1819_CR9","first-page":"299","volume":"23","author":"E de Rizzo","year":"1989","unstructured":"de Rizzo E, Ten\u00f3rio EC, Mendes IF, Fang FL, Pral MM, Takata CS, Miyaki C, Gallina NM, Tuchiya HN, Akimura OK. Sorbitol-gelatin and glutamic acid-lactose solutions for stabilization of reference preparations of measles virus. Bull Pan Am Health Organ. 1989;23(3):299\u2013305.","journal-title":"Bull Pan Am Health Organ"},{"key":"1819_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-8518-5-4","volume":"5","author":"V Liska","year":"2007","unstructured":"Liska V, Bigert SA, Bennett PS, Olsen D, Chang R, Burke CJ. Evaluation of a recombinant human gelatin as a substitute for a hydrolyzed porcine gelatin in a refrigerator-stable Oka\/Merck live varicella vaccine. J Immune Based Ther Vaccines. 2007;5:4.","journal-title":"J Immune Based Ther Vaccines"},{"issue":"2","key":"1819_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1128\/CMR.3.2.120","volume":"3","author":"FB Johnson","year":"1990","unstructured":"Johnson FB. Transport of viral specimens. Clin Microbiol Rev. 1990;3(2):120\u201331.","journal-title":"Clin Microbiol Rev"},{"issue":"1\u20133","key":"1819_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0168-3659(02)00026-3","volume":"80","author":"Y Fukunaka","year":"2002","unstructured":"Fukunaka Y, Iwanaga K, Morimoto K, Kakemi M, Tabata Y. Controlled release of plasmid DNA from cationized gelatin hydrogels based on hydrogel degradation. J Control Release. 2002;80(1\u20133):333\u201343.","journal-title":"J Control Release"},{"issue":"1","key":"1819_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1085\/jgp.4.1.97","volume":"4","author":"J Loeb","year":"1921","unstructured":"Loeb J. The reciprocal relation between the osmotic pressure and the viscosity of gelatin solutions. J Gen Physiol. 1921;4(1):97\u2013112.","journal-title":"J Gen Physiol"},{"issue":"2","key":"1819_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0926-6585(66)90340-2","volume":"120","author":"WF Dudman","year":"1966","unstructured":"Dudman WF. Interaction between gelatin solutions and tobacco mosaic virus. Biochim Biophys Acta. 1966;120(2):212\u201321.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1819_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.24264\/lfj.18.1.7","volume":"18","author":"G Macovescu","year":"2018","unstructured":"Macovescu G. Validation of method for determining the isoelectric point of protein solutions. Leather and footwear journal. 2018;18(1):53\u201366.","journal-title":"Leather and footwear journal"},{"key":"1819_CR16","doi-asserted-by":"crossref","unstructured":"Beitrag zur kollektiven KG. Behandlung pharmakologischer Reihenversuche. Archiv f experiment Pathol u Pharmakol 1 62 (1931) Four 480\u2013483.","DOI":"10.1007\/BF01863914"},{"issue":"17","key":"1819_CR17","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/sj.gt.3301527","volume":"8","author":"MA Croyle","year":"2001","unstructured":"Croyle MA, Cheng X, Wilson JM. Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Ther. 2001;8(17):1281\u201390.","journal-title":"Gene Ther"},{"key":"1819_CR18","volume-title":"Principles and practices, 2nd edn, drugs and the pharmaceutical sciences","author":"D Stability","year":"1995","unstructured":"Stability D. Principles and practices, 2nd edn, drugs and the pharmaceutical sciences, vol. 68. New York: Marcel Dekker; 1995."},{"key":"1819_CR19","unstructured":"International Conference on Harmonization (ICH) Harmonized Tripartite Guideline, Stability Testing of New Drug Substances and Products, 1993."},{"key":"1819_CR20","volume-title":"Thermostability of vaccines","author":"JMA Galazka","year":"1998","unstructured":"Galazka JMA, Zaffran M. Thermostability of vaccines. Geneva: World Health Organization; 1998."},{"issue":"12","key":"1819_CR21","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.3390\/molecules23123257","volume":"23","author":"J Wang","year":"2018","unstructured":"Wang J, Luo D, Liang M, Zhang T, Yin X, Zhang Y, Yang X, Liu W. Spectrum-effect relationships between high-performance liquid chromatography (HPLC) fingerprints and the antioxidant and anti-inflammatory activities of collagen peptides. Molecules. 2018;23(12):3257. https:\/\/doi.org\/10.3390\/molecules23123257.","journal-title":"Molecules."},{"key":"1819_CR22","unstructured":"Potential Vaccine Allergens. https:\/\/www.vaccinesafety.edu\/Components-Allergens%2021-0115.pdf. 2021."},{"key":"1819_CR23","unstructured":"Litowski JR, Siska C, Kerwin BA. Stable frozen herpes simplex virus formulation. In: W.I. Property, Organization, editor. International Bureau, Amgen Inc., US; 2016."},{"issue":"7","key":"1819_CR24","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/v3070941","volume":"3","author":"SV Zaichick","year":"2011","unstructured":"Zaichick SV, Bohannon KP, Smith GA. Alphaherpesviruses and the cytoskeleton in neuronal infections. Viruses. 2011;3(7):941\u201381.","journal-title":"Viruses"},{"issue":"22","key":"1819_CR25","doi-asserted-by":"publisher","first-page":"e01259","DOI":"10.1128\/JVI.01259-18","volume":"92","author":"T Russell","year":"2018","unstructured":"Russell T, Bleasdale B, Hollinshead M, Elliott G. Qualitative differences in capsidless L-particles released as a by-product of bovine herpesvirus 1 and herpes simplex virus 1 infections. J Virol. 2018;92(22):e01259-18. https:\/\/doi.org\/10.1128\/JVI.01259-18.","journal-title":"J Virol."},{"issue":"12","key":"1819_CR26","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1248\/cpb.41.2138","volume":"41","author":"K Yasui","year":"1993","unstructured":"Yasui K, Fujioka H, Nakamura Y. Cryoprotective effect of gelatin and albumin on recombinant human tumor necrosis factor liposome. Chem Pharm Bull (Tokyo). 1993;41(12):2138\u201340.","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"1819_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.foodchem.2017.04.183","volume":"234","author":"M Yasemi","year":"2017","unstructured":"Yasemi M. Prevention of denaturation of freshwater crayfish muscle subjected to different freeze-thaw cycles by gelatin hydrolysate. Food Chem. 2017;234:199\u2013204.","journal-title":"Food Chem"},{"key":"1819_CR28","doi-asserted-by":"publisher","first-page":"111056","DOI":"10.1016\/j.fct.2019.111056","volume":"136","author":"X Chen","year":"2020","unstructured":"Chen X, Li L, Yang F, Wu J, Wang S. Effects of gelatin-based antifreeze peptides on cell viability and oxidant stress of Streptococcus thermophilus during cold stage. Food Chem Toxicol. 2020;136:111056.","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"1819_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0011-2240(03)00046-4","volume":"46","author":"Z Hub\u00e1lek","year":"2003","unstructured":"Hub\u00e1lek Z. Protectants used in the cryopreservation of microorganisms. Cryobiology. 2003;46(3):205\u201329.","journal-title":"Cryobiology"},{"issue":"10","key":"1819_CR30","doi-asserted-by":"publisher","first-page":"eaau4819","DOI":"10.1126\/sciadv.aau4819","volume":"6","author":"I Bajrovic","year":"2020","unstructured":"Bajrovic I, Schafer SC, Romanovicz DK, Croyle MA. Novel technology for storage and distribution of live vaccines and other biological medicines at ambient temperature. Sci Adv. 2020;6(10):eaau4819.","journal-title":"Sci Adv"},{"issue":"10","key":"1819_CR31","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1002\/jps.20157","volume":"93","author":"RK Evans","year":"2004","unstructured":"Evans RK, Nawrocki DK, Isopi LA, Williams DM, Casimiro DR, Chin S, Chen M, Zhu DM, Shiver JW, Volkin DB. Development of stable liquid formulations for adenovirus-based vaccines. J Pharm Sci. 2004;93(10):2458\u201375.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1819_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3126\/njb.v3i1.14224","volume":"3","author":"BK Jha","year":"2015","unstructured":"Jha BK. Effect of lyophilization on infectivity and viral load of adenovirus. Nepal J Biotechnol. 2015;3(1):15\u201321.","journal-title":"Nepal J Biotechnol"},{"issue":"2","key":"1819_CR33","doi-asserted-by":"publisher","first-page":"e01894","DOI":"10.1128\/JVI.01894-18","volume":"93","author":"AJ Snyder","year":"2019","unstructured":"Snyder AJ, Wang JC, Danthi P. Components of the reovirus capsid differentially contribute to stability. J Virol. 2019;93(2):e01894-18. https:\/\/doi.org\/10.1128\/JVI.01894-18.","journal-title":"J Virol."},{"issue":"23","key":"1819_CR34","doi-asserted-by":"publisher","first-page":"10951","DOI":"10.1128\/JVI.01843-16","volume":"90","author":"D Thete","year":"2016","unstructured":"Thete D, Snyder AJ, Mainou BA, Danthi P. Reovirus \u03bc1 protein affects infectivity by altering virus-receptor interactions. J Virol. 2016;90(23):10951\u201362.","journal-title":"J Virol"},{"issue":"Pt 1","key":"1819_CR35","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1099\/0022-1317-63-1-161","volume":"63","author":"D Drayna","year":"1982","unstructured":"Drayna D, Fields BN. Biochemical studies on the mechanism of chemical and physical inactivation of reovirus. J Gen Virol. 1982;63(Pt 1):161\u201370.","journal-title":"J Gen Virol"},{"issue":"Pt 1","key":"1819_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1099\/0022-1317-63-1-149","volume":"63","author":"D Drayna","year":"1982","unstructured":"Drayna D, Fields BN. Genetic studies on the mechanism of chemical and physical inactivation of reovirus. J Gen Virol. 1982;63(Pt 1):149\u201359.","journal-title":"J Gen Virol"},{"key":"1819_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/1471-2334-11-354","volume":"11","author":"X Wang","year":"2011","unstructured":"Wang X, Zoueva O, Zhao J, Ye Z, Hewlett I. Stability and infectivity of novel pandemic influenza A (H1N1) virus in blood-derived matrices under different storage conditions. BMC Infect Dis. 2011;11:354.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"1819_CR38","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1128\/JVI.75.6.2866-2878.2001","volume":"75","author":"K Nealon","year":"2001","unstructured":"Nealon K, Newcomb WW, Pray TR, Craik CS, Brown JC, Kedes DH. Lytic replication of Kaposi\u2019s sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus. J Virol. 2001;75(6):2866\u201378.","journal-title":"J Virol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01819-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-022-01819-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01819-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T11:10:56Z","timestamp":1653649856000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-022-01819-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1186\/s12985-022-01819-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1209181\/v1","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"assertion":[{"value":"4 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"94"}}